| Filed | As-Of/On | Form | Fullname | Symbol | Country | Industry | Shares | Activity | Shares Change | Shares Pct. Change | Hypothetical Old Value | Hypothetical New Value | Hypothetical Value Chg. | Hypothetical Return | Hypothetical Results |
Director |
Other |
Ten Pct |
Officer |
Officer Title |
History |
|---|
| 2009-11-16 | 2009-09-30 | 13F-HR | Gilead Sciences Inc | GILD | US | Therapeutics | 20,376 | Sold Some | -700 | -3.32 % | $966,434 | $956,857 | $-9,577 | -0.99 % | $329 | | | | | | History of Petersen Flynn And Dinsmore Inc Ownership Of Gilead Sciences Inc |
| 2009-08-14 | 2009-06-30 | 13F-HR | Gilead Sciences Inc | GILD | US | Therapeutics | 21,076 | Sold Some | -2,900 | -12.09 % | $947,366 | $989,729 | $42,363 | 4.47 % | $-5,829 | | | | | | History of Petersen Flynn And Dinsmore Inc Ownership Of Gilead Sciences Inc |
| 2009-05-13 | 2009-03-31 | 13F-HR | Gilead Sciences Inc | GILD | US | Therapeutics | 23,976 | Sold Some | -770 | -3.11 % | $1,064,534 | $1,125,913 | $61,379 | 5.76 % | $-1,971 | | | | | | History of Petersen Flynn And Dinsmore Inc Ownership Of Gilead Sciences Inc |
| 2009-02-13 | 2008-12-31 | 13F-HR | Gilead Sciences Inc | GILD | US | Therapeutics | 24,746 | Sold Some | -2,220 | -8.23 % | $1,243,487 | $1,162,072 | $-81,414 | -6.54 % | $7,304 | | | | | | History of Petersen Flynn And Dinsmore Inc Ownership Of Gilead Sciences Inc |
| 2008-11-12 | 2008-09-30 | 13F-HR | Gilead Sciences Inc | GILD | US | Therapeutics | 26,966 | Sold Some | -1,432 | -5.04 % | $1,198,639 | $1,266,323 | $67,685 | 5.64 % | $-3,594 | | | | | | History of Petersen Flynn And Dinsmore Inc Ownership Of Gilead Sciences Inc |
| 2008-08-06 | 2008-06-30 | 13F-HR | Gilead Sciences Inc | GILD | US | Therapeutics | 28,398 | Sold Some | -1,160 | -3.92 % | $1,591,140 | $1,333,570 | $-257,570 | -16.18 % | $10,521 | | | | | | History of Petersen Flynn And Dinsmore Inc Ownership Of Gilead Sciences Inc |
| 2008-05-01 | 2008-03-31 | 13F-HR | Gilead Sciences Inc | GILD | US | Therapeutics | 29,558 | Sold Some | -24,890 | -45.71 % | $1,566,574 | $1,388,044 | $-178,530 | -11.39 % | $150,336 | | | | | | History of Petersen Flynn And Dinsmore Inc Ownership Of Gilead Sciences Inc |
| 2008-02-01 | 2007-12-31 | 13F-HR | Gilead Sciences Inc | GILD | US | Therapeutics | 54,448 | Added More | 1,200 | 2.25 % | $2,500,797 | $2,556,878 | $56,081 | 2.24 % | $1,236 | | | | | | History of Petersen Flynn And Dinsmore Inc Ownership Of Gilead Sciences Inc |
| 2007-11-08 | 2007-09-30 | 13F-HR | Gilead Sciences Inc | GILD | US | Therapeutics | 53,248 | Added More | 600 | 1.13 % | $2,399,887 | $2,500,526 | $100,639 | 4.19 % | $1,134 | | | | | | History of Petersen Flynn And Dinsmore Inc Ownership Of Gilead Sciences Inc |
| 2007-08-10 | 2007-06-30 | 13F-HR | Gilead Sciences Inc | GILD | US | Therapeutics | 52,648 | Added More | 25,994 | 97.52 % | $1,951,135 | $2,472,350 | $521,215 | 26.71 % | $257,341 | | | | | | History of Petersen Flynn And Dinsmore Inc Ownership Of Gilead Sciences Inc |
| 2007-05-04 | 2007-03-31 | 13F-HR | Gilead Sciences Inc | GILD | US | Therapeutics | 26,654 | No Change | 0 | 0 % | $2,215,480 | $1,251,672 | $-963,809 | -43.50 % | $0 | | | | | | History of Petersen Flynn And Dinsmore Inc Ownership Of Gilead Sciences Inc |
| 2007-02-02 | 2006-12-31 | 13F-HR | Gilead Sciences Inc | GILD | US | Therapeutics | 26,654 | Added More | 135 | 0.50 % | $1,883,638 | $1,251,672 | $-631,966 | -33.55 % | $-3,201 | | | | | | History of Petersen Flynn And Dinsmore Inc Ownership Of Gilead Sciences Inc |
| 2006-10-30 | 2006-09-30 | 13F-HR | Gilead Sciences Inc | GILD | US | Therapeutics | 26,519 | Sold Some | -3,756 | -12.40 % | $1,829,015 | $1,245,332 | $-583,683 | -31.91 % | $82,670 | | | | | | History of Petersen Flynn And Dinsmore Inc Ownership Of Gilead Sciences Inc |
| 2006-08-07 | 2006-06-30 | 13F-HR | Gilead Sciences Inc | GILD | US | Therapeutics | 30,275 | No Change | 0 | 0 % | $1,874,931 | $1,421,714 | $-453,217 | -24.17 % | $0 | | | | | | History of Petersen Flynn And Dinsmore Inc Ownership Of Gilead Sciences Inc |
| 2006-05-03 | 2006-03-31 | 13F-HR | Gilead Sciences Inc | GILD | US | Therapeutics | 30,275 | Sold Some | -1,056 | -3.37 % | $1,698,730 | $1,421,714 | $-277,016 | -16.30 % | $9,662 | | | | | | History of Petersen Flynn And Dinsmore Inc Ownership Of Gilead Sciences Inc |
| 2006-01-31 | 2005-12-31 | 13F-HR | Gilead Sciences Inc | GILD | US | Therapeutics | 31,331 | Added More | 650 | 2.11 % | $1,907,118 | $1,471,304 | $-435,814 | -22.85 % | $-9,042 | | | | | | History of Petersen Flynn And Dinsmore Inc Ownership Of Gilead Sciences Inc |
| 2005-10-28 | 2005-09-30 | 13F-HR | Gilead Sciences Inc | GILD | US | Therapeutics | 30,681 | Sold Some | -101 | -0.32 % | $1,445,689 | $1,440,780 | $-4,909 | -0.33 % | $16 | | | | | | History of Petersen Flynn And Dinsmore Inc Ownership Of Gilead Sciences Inc |
| 2005-08-03 | 2005-06-30 | 13F-HR | Gilead Sciences Inc | GILD | US | Therapeutics | 30,782 | Sold Some | -2,250 | -6.81 % | $1,396,272 | $1,445,523 | $49,251 | 3.52 % | $-3,600 | | | | | | History of Petersen Flynn And Dinsmore Inc Ownership Of Gilead Sciences Inc |
| 2005-05-09 | 2005-03-31 | 13F-HR | Gilead Sciences Inc | GILD | US | Therapeutics | 33,032 | Sold Some | -4,850 | -12.80 % | $1,283,954 | $1,551,183 | $267,229 | 20.81 % | $-39,237 | | | | | | History of Petersen Flynn And Dinsmore Inc Ownership Of Gilead Sciences Inc |
| 2005-02-01 | 2004-12-31 | 13F-HR | Gilead Sciences Inc | GILD | US | Therapeutics | 37,882 | No Change | 0 | 0 % | $1,267,532 | $1,778,939 | $511,407 | 40.34 % | $0 | | | | | | History of Petersen Flynn And Dinsmore Inc Ownership Of Gilead Sciences Inc |
| 2004-10-26 | 2004-09-30 | 13F-HR | Gilead Sciences Inc | GILD | US | Therapeutics | 37,882 | Added More | 15,684 | 70.65 % | $1,288,746 | $1,778,939 | $490,193 | 38.03 % | $202,951 | | | | | | History of Petersen Flynn And Dinsmore Inc Ownership Of Gilead Sciences Inc |
| 2004-08-12 | 2004-06-30 | 13F-HR | Gilead Sciences Inc | GILD | US | Therapeutics | 22,198 | Added More | 4,468 | 25.20 % | $1,413,569 | $1,042,418 | $-371,151 | -26.25 % | $-74,705 | | | | | | History of Petersen Flynn And Dinsmore Inc Ownership Of Gilead Sciences Inc |
| 2004-05-05 | 2004-03-31 | 13F-HR | Gilead Sciences Inc | GILD | US | Therapeutics | 17,730 | Sold Some | -150 | -0.83 % | $1,034,368 | $832,601 | $-201,767 | -19.50 % | $1,707 | | | | | | History of Petersen Flynn And Dinsmore Inc Ownership Of Gilead Sciences Inc |
| 2004-02-09 | 2003-12-31 | 13F-HR | Gilead Sciences Inc | GILD | US | Therapeutics | 17,880 | Sold Some | -300 | -1.65 % | $1,032,034 | $839,645 | $-192,389 | -18.64 % | $3,228 | | | | | | History of Petersen Flynn And Dinsmore Inc Ownership Of Gilead Sciences Inc |
| 2003-11-13 | 2003-09-30 | 13F-HR | Gilead Sciences Inc | GILD | US | Therapeutics | 18,180 | Sold Some | -930 | -4.86 % | $1,000,627 | $853,733 | $-146,894 | -14.68 % | $7,514 | | | | | | History of Petersen Flynn And Dinsmore Inc Ownership Of Gilead Sciences Inc |
| 2003-08-12 | 2003-06-30 | 13F-HR | Gilead Sciences Inc | GILD | US | Therapeutics | 19,110 | Sold Some | -5,710 | -23.00 % | $1,219,982 | $897,406 | $-322,577 | -26.44 % | $96,385 | | | | | | History of Petersen Flynn And Dinsmore Inc Ownership Of Gilead Sciences Inc |
| 2003-05-13 | 2003-03-31 | 13F-HR | Gilead Sciences Inc | GILD | US | Therapeutics | 24,820 | Sold Some | -810 | -3.16 % | $1,163,065 | $1,165,547 | $2,482 | 0.21 % | $-81 | | | | | | History of Petersen Flynn And Dinsmore Inc Ownership Of Gilead Sciences Inc |
| 2003-02-03 | 2002-12-31 | 13F-HR | Gilead Sciences Inc | GILD | US | Therapeutics | 25,630 | Sold Some | -8,240 | -24.32 % | $885,004 | $1,203,585 | $318,581 | 35.99 % | $-102,423 | | | | | | History of Petersen Flynn And Dinsmore Inc Ownership Of Gilead Sciences Inc |
| 2002-11-12 | 2002-09-30 | 13F-HR | Gilead Sciences Inc | GILD | US | Therapeutics | 33,870 | Added More | 21,124 | 165.73 % | $1,214,578 | $1,590,535 | $375,957 | 30.95 % | $234,476 | | | | | | History of Petersen Flynn And Dinsmore Inc Ownership Of Gilead Sciences Inc |
| 2000-05-23 | 2000-03-31 | 13F-HR | Gilead Sciences Inc | GILD | US | Therapeutics | 12,746 | No Change | 0 | 0 % | $771,898 | $598,552 | $-173,346 | -22.45 % | $0 | | | | | | History of Petersen Flynn And Dinsmore Inc Ownership Of Gilead Sciences Inc |
| 2000-05-19 | 1999-12-31 | 13F-HR | Gilead Sciences Inc | GILD | US | Therapeutics | 12,746 | No Compare | - | - % | $762,211 | $598,552 | $-163,659 | -21.47 % | | | | | | | History of Petersen Flynn And Dinsmore Inc Ownership Of Gilead Sciences Inc |
![]() |
| |
Note: All amounts are based on price of stock at date reported versus the current price! They do not represent actual profit/loss!
There has been no adjustmentsfor splits! |
| Note: All amounts in USD, converted using Intrabank Exchange Rate on Date Reported/Today |
|
Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice, and may be inaccurate!
|
| Note: For security reasons, only (A-Z,a-z,0-9,space,period,colon,comma,forward slash,at) can be inputed - all others are stripped automatically! |
|
Copyright © 2007 All rights reserved. Please see our Terms of Use.
|
|
![]() |